CA2965129C — Method of treating ocular conditions using varenicline
Assigned to Oyster Point Pharma Inc · Expires 2024-03-12 · 2y expired
What this patent protects
Described herein are methods and pharmaceutical formulations for treating ocular conditions. More specifically, here are described formulations and preparations for nasal administration comprising a nicotinic acetylcholine receptor agonist for use in treating ocular conditions.
USPTO Abstract
Described herein are methods and pharmaceutical formulations for treating ocular conditions. More specifically, here are described formulations and preparations for nasal administration comprising a nicotinic acetylcholine receptor agonist for use in treating ocular conditions.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.